Thomas Linn
Justus-Liebig-Universität Gießen(DE)Frimley Park Hospital(GB)Frimley Health NHS Foundation Trust(GB)
Publications by Year
Research Areas
Pancreatic function and diabetes, Diabetes and associated disorders, Diabetes Management and Research, Diabetes Treatment and Management, Diet and metabolism studies
Most-Cited Works
- → Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.(1993)837 cited
- → 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial(2017)824 cited
- → The Pattern Recognition Receptor (RAGE) Is a Counterreceptor for Leukocyte Integrins(2003)574 cited
- → Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial(2008)305 cited
- → Diabetes-induced hyperglycemia impairs male reproductive function: a systematic review(2017)280 cited
- → Effect of long-term dietary protein intake on glucose metabolism in humans(2000)